India is witnessing a surge in cancer cases, with an estimated 800,000 new diagnoses annually. The increase is attributed to ...

More people are getting cancer in their 20s, 30s, and 40s, and surviving, thanks to rapid advancement in care. Many will have ...

Axicabtagene ciloleucel, known by the brand name Yescarta, has been accepted for treating adults with two types of blood cancer.